Jason Amello
CorpContrllr,ChiefAccntOfficer, GENZYME CORP.
Companies
- TScan Therapeutics, Inc.Chief financial officer Feb 2, 2024 to now1
- Candel TherapeuticsChief financial officer Sep 23, 2022 to Nov 30, 20232
- Opexa TherapeuticsBoard member Sep 21, 2017 to Mar 16, 20233
- Akebia Therapeutics, Inc.Chief financial officer Mar 19, 2014 to Mar 2, 20204
- ZIOPHARM OncologyChief financial officer May 10, 2012 to May 14, 20135
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Candel Therapeutics CADL202,009 shares6$1.6M at $8.14Nov 28, 2023
As of each latest filing. The line shows shares held over time.
Recent filings
- Nov 28, 2023Shares withheld for tax 20,153 shares at $0.90 of Candel Therapeutics6
- Nov 26, 2023Granted 125,717 shares of Candel Therapeutics7
- Dec 9, 2022Bought 2,468 shares at $1.93 of Candel Therapeutics8
- Dec 8, 2022Bought 3,100 shares at $1.69 of Candel Therapeutics8
- Nov 28, 2022Granted 90,877 shares of Candel Therapeutics9
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGAROpexa Therapeutics, Board member
- 4
- 5
- 6
- 7SEC EDGARForm 4 filed Nov 28, 2023
- 8SEC EDGARForm 4 filed Dec 12, 2022
- 9SEC EDGARForm 4 filed Nov 30, 2022